Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 219 member A (FAM219A) is a human protein encoded by the C9orf25 gene, located on chromosome 9 at 9p13.3. The protein is composed of 185 amino acids, with a molecular weight of 20.4 kDa and predicted cytosolic localization, lacking a signal sequence. It belongs to the FAM219 superfamily (Pfam PF15260), but remains a domain of unknown function, with no clear catalytic, receptor, or transport roles as of current knowledge. FAM219A is expressed in many tissues, with higher expression in the nervous, digestive, and male reproductive systems. Multiple transcript variants exist, with some encoding protein isoforms. FAM219A interacts with diverse proteins, some of which have disease associations, but it is not itself directly implicated in pathology. Experimental evidence for its biological process or molecular function is still lacking; therefore, it is currently categorized as a protein with unknown function and has no established therapeutic significance.
None known. No mechanisms of drug action are described for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 219 member A (FAM219A).